128 related articles for article (PubMed ID: 12765123)
1. [Reconstitution of cyclophosphamide-induced, impaired function of the immune system in animal models].
Artym J
Postepy Hig Med Dosw; 2003; 57(1):55-66. PubMed ID: 12765123
[TBL] [Abstract][Full Text] [Related]
2. Normalization of peripheral blood cell composition by lactoferrin in cyclophosphamide-treated mice.
Artym J; Zimecki M; Kruzel M
Med Sci Monit; 2004 Mar; 10(3):BR84-9. PubMed ID: 14976460
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulant and chemoprotective effect of vivartana, a polyherbal formulation against cyclophosphamide induced toxicity in Swiss albino mice.
Gnanasekaran S; Sakthivel KM; Chandrasekaran G
J Exp Ther Oncol; 2015; 11(1):51-61. PubMed ID: 26259390
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory function of lactoferrin in immunosuppressed and autoimmune animals.
Zimecki M; Artym J; Chodaczek G; Kocieba M; Kuryszko J; Houszka M; Kruzel ML
Postepy Hig Med Dosw (Online); 2007; 61():283-7. PubMed ID: 17507877
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens.
Emmenegger U; Man S; Shaked Y; Francia G; Wong JW; Hicklin DJ; Kerbel RS
Cancer Res; 2004 Jun; 64(11):3994-4000. PubMed ID: 15173013
[TBL] [Abstract][Full Text] [Related]
6. [The effect of platinum-containing cytostatic preparations on the immune and hematopoietic systems].
Masnaia NV; Ratner GM
Eksp Klin Farmakol; 1999; 62(1):53-5. PubMed ID: 10198769
[TBL] [Abstract][Full Text] [Related]
7. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
Zuluaga AF; Salazar BE; Rodriguez CA; Zapata AX; Agudelo M; Vesga O
BMC Infect Dis; 2006 Mar; 6():55. PubMed ID: 16545113
[TBL] [Abstract][Full Text] [Related]
8. A clinician's comments on the cyclophosphamide hematotoxicity biologically based risk assessment model.
Atkins HL
J Toxicol Environ Health A; 2000 Nov; 61(5-6):529-38. PubMed ID: 11086964
[No Abstract] [Full Text] [Related]
9. [The effects of Polyrhachis vicina on immunoregulation in mice].
Cai Y; Yu G
Zhong Yao Cai; 2001 Jul; 24(7):499-502. PubMed ID: 11668743
[TBL] [Abstract][Full Text] [Related]
10. [Morphofunctional changes in the thyroid gland after cyclophosphamide administration and their reversibility].
Iukina GIu; Bykov VL
Morfologiia; 2001; 120(4):49-53. PubMed ID: 11586650
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships of cytotoxicity, PFC response and histology in the spleen in rats treated with alkylating agents.
Doi T; Nagai H; Tsukuda R; Suzuki T
Toxicology; 1996 Jan; 107(1):47-60. PubMed ID: 8597031
[TBL] [Abstract][Full Text] [Related]
12. Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells.
Tripathi DN; Jena GB
Toxicology; 2008 Jun; 248(2-3):96-103. PubMed ID: 18485558
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease.
Moraes-Fontes MF; Rebelo M; Caramalho I; Zelenay S; Bergman ML; Coutinho A; Demengeot J
J Autoimmun; 2009 Sep; 33(2):109-20. PubMed ID: 19362805
[TBL] [Abstract][Full Text] [Related]
15. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
Artym J; Zimecki M; Kruzel ML
Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
[TBL] [Abstract][Full Text] [Related]
16. The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy.
Ahlmann M; Hempel G
Cancer Chemother Pharmacol; 2016 Oct; 78(4):661-71. PubMed ID: 27646791
[TBL] [Abstract][Full Text] [Related]
17. Association of Ipomoea carnea and BCG reduces birth defects caused by cyclophosphamide in rats.
Latorre AO; Hueza IM; Górniak SL
Life Sci; 2007 Jan; 80(5):430-5. PubMed ID: 17070555
[TBL] [Abstract][Full Text] [Related]
18. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
Ma J; Wang YL; Hu HM; Fox BA; Si LS
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
[TBL] [Abstract][Full Text] [Related]
19. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
Artym J; Zimecki M; Kruzel ML
Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
[TBL] [Abstract][Full Text] [Related]
20. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]